Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,521 | 22,865 | 27,812 | N/A | N/A |
| TOTAL | $101,090 | $26,164 | $28,442 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 157 | 127 | 91 | N/A | N/A |
| Other Non-Current Assets | 0 | 10 | 10 | 0 | 0 |
| TOTAL | $157 | $137 | $101 | $N/A | $N/A |
| Total Assets | $101,247 | $26,302 | $28,543 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,432 | 2,638 | 929 | 0 | 0 |
| Accrued Expenses | 2,691 | 1,699 | 1,486 | N/A | N/A |
| TOTAL | $6,123 | $4,337 | $2,415 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,123 | $4,337 | $2,415 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,863 | 3,657 | N/A | N/A | N/A |
| Common Shares | 15 | 2 | 2 | N/A | N/A |
| Retained earnings | -136,185 | -130,333 | -126,019 | N/A | N/A |
| Other shareholders' equity | 0 | 41,880 | 41,880 | 0 | 0 |
| TOTAL | $95,124 | $21,965 | $26,128 | $N/A | $N/A |
| Total Liabilities And Equity | $101,247 | $26,302 | $28,543 | $0 | $0 |